Sildenafil Tablet, Film Coated
Product Images NDC 70518-1844

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 70518-1844). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafil 50mg 70518 1844 00

Sildenafil 50 mg oral film-coated tablets label by RemedyRepack Inc. The label states the quantity as 30 tablets and notes the product is prescription-only (RX ONLY). It includes the NDC number 70518-1844-00, manufacturer details (Camber Pharma, Inc., Piscataway, NJ), and storage directions with a QR code visible on the right side.*

FDA Label Image

Sildenafilfigure7 (Sildenafilfigure7)

A vertical bar chart showing the percentage of patients reporting improvement by treatment group. The groups include Placebo, and Sildenafil Citrate Tablets at 25 mg, 50 mg, and 100 mg, with improvement percentages increasing from Placebo to 100 mg dose.*

FDA Label Image

Sildenafilfigure1 (Sildenafilfigure1)

A line graph depicting the changes in systolic blood pressure (mmHg) over 24 hours post dose, comparing Sildenafil 100 mg with placebo. The x-axis represents time in hours from pre-dose to 24 hours, and the y-axis shows changes in systolic blood pressure from approximately -25 to +15 mmHg. Two data series are shown with distinct markers for Sildenafil and placebo.*

FDA Label Image

Sildenafilfigure2 (Sildenafilfigure2)

A line graph showing the change in blood pressure (mmHg) over time (hours) for two treatment groups. The graph compares the effects of placebo and a 50 mg dose of sildenafil on blood pressure reduction, with time expressed along the horizontal axis and change in blood pressure on the vertical axis.*

FDA Label Image

Sildenafilfigure3 (Sildenafilfigure3)

A line graph showing changes in a measured variable over time postdose (hours). It compares two groups: 'Dicloxacillin + Placebo' and 'Dicloxacillin + Sildenafil 50 mg'. The y-axis represents percent change, and the x-axis represents time in hours.*

FDA Label Image

Sildenafilfigure4 (Sildenafilfigure4)

A line graph comparing the effects of Doxazosin combined with Sildenafil 100 mg and Doxazosin combined with placebo over time after dosing, measured in hours. The y-axis represents a numerical scale from -50 to 40, while the x-axis shows time after dosing from 0 to 8 hours. Two data lines with distinct markers show the trends for each combination during the 8-hour period.*

FDA Label Image

Sildenafilfigure5 (Sildenafilfigure5)

A line graph depicting plasma concentration (ng/mL) of Sildenafil over time post-dose (hours). The plot shows concentration peaking early, then gradually declining over 24 hours for the treatment labeled as Commercial Tablet.*

FDA Label Image

Sildenafilfigure6a (Sildenafilfigure6a)

A bar chart showing the percentage of patients at endpoint plotted against baseline scores ranging from 0 to 5. Different bars represent various categories indicated by a legend with values from 0 to 5, showing changes in patient percentages across baseline scores.*

FDA Label Image

Sildenafilfigure6b (Sildenafilfigure6b)

A bar chart showing the percentage of patients at endpoint across baseline scores from 0 to 5. Each baseline score category is subdivided into six bars labeled 0 through 5, representing different groups or categories. The y-axis indicates the percentage of patients, and the x-axis displays baseline scores.*

FDA Label Image

Sildenafilstructure (Sildenafilstructure)

Chemical structure of Sildenafil shown with its molecular components, including ring structures, nitrogen atoms, and functional groups, presented in a black-and-white line drawing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.